ELV Elevance Health, Inc. | US0367521038
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 200.388.921.110 | 196.237.836.900 | 2.12% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 29,63 | 27,16 | 9.12% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 21 | 20 | 5.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |